Sobi continues the R&D transformation – Anders Ullman appointed new Head of R&D
Anders Ullman, M.D., Ph.D., currently a member of the Board of Directors of Sobi, will become Head of R&D and Chief Medical Officer and replace Ravi Rao, M.D., Ph.D. Dr Ullman brings extensive experience and knowledge from the global pharmaceutical industry having previously led R&D organisations and change processes in other companies, including Bayer, Nycomed and Baxter. In support of the transformation, Dr Ullman will be based in Basel, Switzerland, report to CEO Guido Oelkers and become a member of the Sobi Executive Committee. Guido Oelkers: “We welcome Anders in his new capacity